CIAM
VNDA icon

Caitong International Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Caitong International Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$930 Sell
152
-5,321
-97% -$34.8K ﹤0.01% 1564
2026
Q1 		$37.8K Sell
5,473
-23,685
-81% -$183K 0.01% 864
2025
Q4 		$257K Buy
29,158
+28,824
+8,630% +$159K 0.06% 152
2025
Q3 		$1.67K Sell
334
-330
-50% -$1.53K ﹤0.01% 1404
2025
Q2 		$3.13K Buy
+664
New +$2.9K ﹤0.01% 1215

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caitong International Asset Management's VNDA Position: Q2 2026 in Review

Caitong International Asset Management reduced its Vanda Pharmaceuticals (VNDA) stake by 97% in Q2 2026, selling an estimated $34.8K and leaving 152 shares worth $930. The position accounts for ﹤0.01% of the portfolio, ranked #1564.

Caitong International Asset Management first reported a position in VNDA in Q2 2025 and has held it in 5 quarters since. The position peaked at $257K in Q4 2025. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Caitong International Asset Management held 152 shares of Vanda Pharmaceuticals worth $930 as of Q2 2026.
  • Caitong International Asset Management sold 5,321 Vanda Pharmaceuticals shares in Q2 2026, an estimated $34.8K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1564 holding.
  • Caitong International Asset Management first reported a position in Vanda Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's Vanda Pharmaceuticals position peaked at $257K in Q4 2025.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.